Total L-carnitine and insulin resistance in non-obese and obese Iraqi women with polycystic ovary syndrome

Total L-carnitine and insulin resistance in non-obese and obese Iraqi women with polycystic ovary syndrome

Show other versions (1)

Background: Polycystic ovary syndrome (PCOS) is one of the most frequent endocrine illnesses affecting reproductive - age women. L-carnitine has important roles in oxidative stress, energy production and glucose metabolism. It affects insulin resistance as decreased plasma carnitine level has been...

Full description

Bibliographic Details
Main Authors:	Maad M. Shallal, Najmah Mahmood, Zina A. Hussein
Format:	Article
Language:	English
Published:	College of Medicine University of Baghdad 2023-04-01
Series:	مجلة كلية الطب
Subjects:	L-Carnitine, Insulin resistance, PCOS : L-Carnitine, Insulin resistance, Obesity, Women, PCOS.
Online Access:	https://www.iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/2040

Similar Items

Total L-carnitine and insulin resistance in non-obese and obese Iraqi women with polycystic ovary syndrome
by: Maad M. Shallal, et al.
Published: (2023-04-01)

Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients
by: Tabatha Petrillo, et al.
Published: (2022-08-01)

Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders
by: Herrera MD, et al.
Published: (2011-03-01)

The Relationship between Macronutrient Intake and Insulin Resistance in Polycystic Ovary Syndrome
by: Mahboobe Gholami, et al.
Published: (2023-05-01)

Regulatory Functions of L-Carnitine, Acetyl, and Propionyl L-Carnitine in a PCOS Mouse Model: Focus on Antioxidant/Antiglycative Molecular Pathways in the Ovarian Microenvironment
by: Giovanna Di Emidio, et al.
Published: (2020-09-01)

Association of galactose and insulin resistance in polycystic ovary syndrome: A case-control study
by: Zhijing Na, et al.
Published: (2022-05-01)

Need to Introduce the Finding of Obesity or Normal Body Weight in the Current Diagnostic Criteria and in the Classification of PCOS
by: Enrico Carmina
Published: (2022-10-01)

Effect of pioglitazone treatment on serum chemerin and vaspin levels in polycystic ovary syndrome.
by: Rana Hussein Kutaif, et al.
Published: (2022-04-01)

Serum leptin level in obese women with polycystic ovary syndrome, and its relation to insulin resistance
by: Azhar Mohammad Nomair, et al.
Published: (2014-12-01)

Comparing Lean and Obese PCOS in Different PCOS Phenotypes: Evidence That the Body Weight Is More Important than the Rotterdam Phenotype in Influencing the Metabolic Status
by: Enrico Carmina, et al.
Published: (2022-09-01)

The efficacy of L-carnitine in patients with nonalcoholic steatohepatitis and concomitant obesity
by: Natalia Zakharova, et al.
Published: (2023-07-01)

Anti-Inflammatory Effects of Curcumin on Insulin Resistance Index, Levels of Interleukin-6, C-Reactive Protein, and Liver Histology in Polycystic Ovary Syndrome-Induced Rats
by: Shima Mohammadi, et al.
Published: (2017-08-01)

Evaluation of serum adiponectin as a marker of insulin resistance in women with polycystic ovarian syndrome: a comparative cross-sectional study
by: Olugbenga Ojatokunbo Runsewe, et al.
Published: (2024-02-01)

Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review
by: Fang-fang He, et al.
Published: (2020-06-01)

The contribution of hyperinsulinemia to the hyperandrogenism of polycystic ovary syndrome
by: Nadia B. Pateguana, et al.
Published: (2019-07-01)

High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome
by: Tayebe Hemati, et al.
Published: (2011-01-01)

Combination of electroacupuncture and pharmacological treatment improves insulin resistance in women with polycystic ovary syndrome: Double-blind randomized clinical trial
by: Raden Muharam, et al.
Published: (2022-04-01)

Effects of Metformin on Menstrual Cyclicity in Women with Polycystic Ovary Syndrome
by: Ülkü Bayar, et al.
Published: (2006-08-01)

Genetic rodent models of obesity-associated ovarian dysfunction and subfertility: insights into polycystic ovary syndrome
by: Isabel eHuang-Doran, et al.
Published: (2016-06-01)

Analysis of the effect of hashimoto's thyroiditis and insulin resistance on ovarian volume in patients with polycystic ovary syndrome
by: Gülcan Gencer, et al.
Published: (2023-02-01)

Neuroendocrine Effects of Carnitines on Reproductive Impairments
by: Tabatha Petrillo, et al.
Published: (2021-10-01)

Carnitine Orotate Complex Ameliorates Insulin Resistance and Hepatic Steatosis Through Carnitine Acetyltransferase Pathway
by: Jung-Hee Hong, et al.
Published: (2021-11-01)

Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome
by: Gourgari E, et al.
Published: (2016-08-01)

Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study
by: Aisa Ghaffarzad, et al.
Published: (2016-04-01)

The Comparative Effects of Myo-Inositol and Metformin Therapy on the Clinical and Biochemical Parameters of Women of Normal Weight Suffering from Polycystic Ovary Syndrome
by: Aleksandra Gudović, et al.
Published: (2024-02-01)

The Potential for Ketogenic Diets to Control Glucotoxicity, Hyperinsulinemia, and Insulin Resistance to Improve Fertility in Women with Polycystic Ovary Syndrome
by: Leticia Ramírez-Martínez, et al.
Published: (2024-03-01)

Investigation of serum asprosin level in patients diagnosed of polycystic ovary syndrome in adolescent age
by: Merve Gungor, et al.
Published: (2022-12-01)

Polycystic ovary syndrome: clinical implication in perimenopause
by: Monika Lenart-Lipińska, et al.
Published: (2014-12-01)

State insulin resistance, the intensity of endogenous intoxication in patients with chronic pancreatitis against obesity treatment in the dynamics of L-carnitine and L-glutathione
by: O. S. Khuhlina, et al.
Published: (2016-12-01)

Frequency and correlates of comorbid depression in polycystic ovary syndrome
by: A B M Kamrul-Hasan, et al.
Published: (2020-06-01)

Interleukin–33, Oxidative Stress in Prediabetic Polycystic Ovary Syndrome Patients with Insulin Resistance
by: Wafa F. Al-Taie, et al.
Published: (2014-04-01)

Association of Circulating Spexin Levels with Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Women and Normal Controls
by: Maliha Shameem, et al.
Published: (2023-12-01)

Association of Circulating Spexin Levels with Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Women and Normal Controls
by: Maliha Shameem, et al.
Published: (2023-12-01)

Correlation between serum adiponectin and clinical characteristics, biochemical parameters in Indian women with polycystic ovary syndrome
by: Sunita J Ramanand, et al.
Published: (2014-01-01)

Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS)
by: Anna Maria Fulghesu, et al.
Published: (2021-07-01)

Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS)
by: Svetlana Spremović Rađenović, et al.
Published: (2022-01-01)

Modulating Morphological and Redox/Glycative Alterations in the PCOS Uterus: Effects of Carnitines in PCOS Mice
by: Maria Grazia Palmerini, et al.
Published: (2023-01-01)

Cardiovascular system diseases in patients with polycystic ovary syndrome – the role of inflammation process in this pathology and possibility of early diagnosis and prevention
by: Aleksandra Marciniak, et al.
Published: (2016-09-01)

Unfavorable Associations Between Serum Trimethylamine N-Oxide and L-Carnitine Levels With Components of Metabolic Syndrome in the Newfoundland Population
by: Xiang Gao, et al.
Published: (2019-03-01)

MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity
by: Francesca Cirillo, et al.
Published: (2019-12-01)